Ann‐Kathrin Bittner

1.2k total citations
39 papers, 790 citations indexed

About

Ann‐Kathrin Bittner is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research. According to data from OpenAlex, Ann‐Kathrin Bittner has authored 39 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Ann‐Kathrin Bittner's work include Medical Imaging Techniques and Applications (17 papers), Radiomics and Machine Learning in Medical Imaging (16 papers) and Breast Cancer Treatment Studies (8 papers). Ann‐Kathrin Bittner is often cited by papers focused on Medical Imaging Techniques and Applications (17 papers), Radiomics and Machine Learning in Medical Imaging (16 papers) and Breast Cancer Treatment Studies (8 papers). Ann‐Kathrin Bittner collaborates with scholars based in Germany, United States and Brazil. Ann‐Kathrin Bittner's co-authors include Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir‐Bauer, Lisa König, Vera Rebmann, Peter A. Horn, Ken Herrmann, Gerald Antoch, Bettina Wagner and Lale Umutlu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Ann‐Kathrin Bittner

39 papers receiving 784 citations

Peers

Countries citing papers authored by Ann‐Kathrin Bittner

Since Specialization

Citations

This map shows the geographic impact of Ann‐Kathrin Bittner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Kathrin Bittner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Kathrin Bittner more than expected).

Fields of papers citing papers by Ann‐Kathrin Bittner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann‐Kathrin Bittner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Kathrin Bittner. The network helps show where Ann‐Kathrin Bittner may publish in the future.

Co-authorship network of co-authors of Ann‐Kathrin Bittner

This figure shows the co-authorship network connecting the top 25 collaborators of Ann‐Kathrin Bittner. A scholar is included among the top collaborators of Ann‐Kathrin Bittner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann‐Kathrin Bittner. Ann‐Kathrin Bittner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer 2024 ·Archives of Gynecology and Obstetrics ·Andy Göbel, Tilman D. Rachner, Oliver Hoffmann, Daniel Martin Klotz, Sabine Kasimir‐Bauer, Rainer Kimmig, Lorenz C. Hofbauer, Ann‐Kathrin Bittner	3
2	Conventional Imaging, MRI and 18F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer 2023 ·Cancers ·Janna Morawitz, Nils Martin Bruckmann, (unknown), Frederic Dietzel, Aleksandar Milošević, Ann‐Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, (unknown), Wolfgang P. Fendler, Ken Herrmann, Frederik L. Giesel, Gerald Antoch, Lale Umutlu, Bernd Kowall, Andreas Stang, Julian Kirchner	3
3	Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer 2023 ·Cancers ·(unknown), Ann‐Kathrin Bittner, Nils Martin Bruckmann, Janna Morawitz, (unknown), Frederic Dietzel, Harald H. Quick, Hideo A. Baba, Ken Herrmann, Lale Umutlu, Gerald Antoch, Julian Kirchner, Sabine Kasimir‐Bauer, Oliver Hoffmann	2
4	Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients 2023 ·Frontiers in Immunology ·Oliver Hoffmann, (unknown), Ann‐Kathrin Bittner, (unknown), (unknown), Sabine Schramm, Hana Rohn, Peter A. Horn, Rainer Kimmig, Sabine Kasimir‐Bauer, Vera Rebmann	1
5	Towards a fast PET/MRI protocol for breast cancer imaging: maintaining diagnostic confidence while reducing PET and MRI acquisition times 2023 ·European Radiology ·(unknown), (unknown), Nils Martin Bruckmann, Janna Morawitz, Frederic Dietzel, Kelsey L. Pomykala, Ken Herrmann, Ann‐Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Lale Umutlu, Gerald Antoch, Harald H. Quick, Julian Kirchner	2
6	The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy 2022 ·Breast Care ·(unknown), Cornelia Kolberg‐Liedtke, Ann‐Kathrin Bittner, Oliver Hoffmann, (unknown), (unknown), (unknown), Hans‐Christian Kolberg	4
7	Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer 2022 ·Cancers ·Lale Umutlu, Julian Kirchner, Nils Martin Bruckmann, Janna Morawitz, Gerald Antoch, Saskia Ting, Ann‐Kathrin Bittner, Oliver Hoffmann, (unknown), Eugen Ruckhäberle, Onofrio A. Catalano, (unknown), Johannes Grueneisen, Harald H. Quick, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Peter Gibbs, Katja Pinker	31
8	Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI—Clinically Relevant? 2022 ·Cancers ·(unknown), Nils Martin Bruckmann, (unknown), Janna Morawitz, Frederic Dietzel, Christoph Rischpler, Ken Herrmann, Ann‐Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Harald H. Quick, Lale Umutlu, Gerald Antoch, Julian Kirchner	2
9	A Role of PET/MR in Breast Cancer? 2022 ·Seminars in Nuclear Medicine ·Nils Martin Bruckmann, Janna Morawitz, Wolfgang P. Fendler, Eugen Ruckhäberle, Ann‐Kathrin Bittner, Frederik L. Giesel, Ken Herrmann, Gerald Antoch, Lale Umutlu, Julian Kirchner	15
10	Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Janna Morawitz, Nils Martin Bruckmann, Frederic Dietzel, T. Ullrich, Ann‐Kathrin Bittner, Oliver Hoffmann, Eugen Ruckhäberle, Svjetlana Mohrmann, (unknown), Marc Ingenwerth, Daniel B. Abrar, Lino M. Sawicki, (unknown), Wolfgang P. Fendler, Ken Herrmann, Christian Buchbender, Gerald Antoch, Lale Umutlu, Julian Kirchner	39
11	Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including ¹⁸F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the Reference Standard 2021 ·Journal of Nuclear Medicine ·Janna Morawitz, Nils Martin Bruckmann, Frederic Dietzel, T. Ullrich, Ann‐Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, (unknown), Marc Ingenwerth, Lale Umutlu, Wolfgang P. Fendler, Tanja Fehm, Ken Herrmann, Gerald Antoch, Lino M. Sawicki, Julian Kirchner	10
12	Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results 2021 ·PLoS ONE ·Nils Martin Bruckmann, Julian Kirchner, Janna Morawitz, Lale Umutlu, Ken Herrmann, Ann‐Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Marc Ingenwerth, Benedikt M. Schaarschmidt, Yan Li, Andreas Stang, Gerald Antoch, Lino M. Sawicki, Christian Buchbender	16
13	Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer 2021 ·Journal of Cancer Research and Clinical Oncology ·Tilman D. Rachner, Sabine Kasimir‐Bauer, (unknown), Kati Erdmann, Oliver Hoffmann, Martina Rauner, Lorenz C. Hofbauer, Rainer Kimmig, Ann‐Kathrin Bittner	24
14	Impact of 18F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients – A prospective evaluation of staging algorithms 2020 ·European Journal of Radiology ·Julian Kirchner, Ole Martin, Lale Umutlu, Ken Herrmann, Ann‐Kathrin Bittner, Oliver Hoffmann, (unknown), Thomas Gauler, Sarah Theurer, Christina Antke, Iréne Esposito, Sonja Kinner, Benedikt M. Schaarschmidt, Bernd Kowall, (unknown), Andreas Stang, Anton S. Becker, Gerald Antoch, Christian Buchbender	14
15	Prospective evaluation of whole-body MRI and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Nils Martin Bruckmann, Lino M. Sawicki, Julian Kirchner, Ole Martin, Lale Umutlu, Ken Herrmann, Wolfgang P. Fendler, Ann‐Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Frederic Dietzel, Marc Ingenwerth, Benedikt M. Schaarschmidt, Yan Li, Bernd Kowall, Andreas Stang, Gerald Antoch, Christian Buchbender	19
16	Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer 2020 ·Frontiers in Oncology ·Sabine Kasimir‐Bauer, Corinna Keup, Oliver Hoffmann, Siegfried Hauch, Rainer Kimmig, Ann‐Kathrin Bittner	17
17	Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patients 2019 ·Cellular and Molecular Life Sciences ·Corinna Keup, (unknown), Siegfried Hauch, Markus Sprenger‐Haussels, Mitra Tewes, Paweł Mach, Ann‐Kathrin Bittner, Rainer Kimmig, Peter F. Hahn, Sabine Kasimir‐Bauer	32
18	Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer 2018 ·Clinical Cancer Research ·Tilman D. Rachner, Sabine Kasimir‐Bauer, Andy Göbel, Kati Erdmann, Oliver Hoffmann, Andrew Browne, Pauline Wimberger, Martina Rauner, Lorenz C. Hofbauer, Rainer Kimmig, Ann‐Kathrin Bittner	29
19	Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Julian Kirchner, Johannes Grueneisen, Ole Martin, (unknown), Harald H. Quick, Ann‐Kathrin Bittner, Oliver Hoffmann, Marc Ingenwerth, Onofrio A. Catalano, Philipp Heusch, Christian Buchbender, Michael Forsting, Gerald Antoch, Ken Herrmann, Lale Umutlu	27
20	Hormone-induced delayed ovulation affects early embryonic development 2011 ·Fertility and Sterility ·Ann‐Kathrin Bittner, Bernhard Horsthemke, Elke Winterhager, Ruth Grümmer	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact